Fig. 2: Outcomes according to the ELN2022 genetic risk groups at diagnosis within patients transplanted in first morphologic remission (n = 337).
A Cumulative incidence of relapse, B Event-free survival, and C Overall survival.
Fig. 2: Outcomes according to the ELN2022 genetic risk groups at diagnosis within patients transplanted in first morphologic remission (n = 337). | Blood Cancer Journal
